-
1
-
-
0038387494
-
5-fluorouracil: Mechanisms of action and clinical strategies
-
5
-
DB Longley DP Harkin PG Johnston 2003 5-fluorouracil: mechanisms of action and clinical strategies Nat Rev Cancer 3 5 330 338
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 330-338
-
-
Longley, D.B.1
Harkin, D.P.2
Johnston, P.G.3
-
2
-
-
33745268219
-
Reassessment of the role of induction chemotherapy for head and neck cancer
-
7
-
MK Gibson AA Forastiere 2006 Reassessment of the role of induction chemotherapy for head and neck cancer Lancet Oncol 7 7 565 574
-
(2006)
Lancet Oncol
, vol.7
, pp. 565-574
-
-
Gibson, M.K.1
Forastiere, A.A.2
-
3
-
-
27144524082
-
New approaches to enhance chemotherapy in SCCHN
-
Suppl 6
-
J Bourhis 2005 New approaches to enhance chemotherapy in SCCHN Ann Oncol 16 Suppl 6 vi20 vi4
-
(2005)
Ann Oncol
, vol.16
-
-
Bourhis, J.1
-
4
-
-
0033970910
-
Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: Implications for fluoropyrimidine radiosensitization
-
1
-
HS Hwang TW Davis JA Houghton TJ Kinsella 2000 Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization Cancer Res 60 1 92 100
-
(2000)
Cancer Res
, vol.60
, pp. 92-100
-
-
Hwang, H.S.1
Davis, T.W.2
Houghton, J.A.3
Kinsella, T.J.4
-
5
-
-
0041426460
-
Platinum-based anticancer agents: Innovative design strategies and biological perspectives
-
5
-
YP Ho SC Au-Yeung KK To 2003 Platinum-based anticancer agents: innovative design strategies and biological perspectives Med Res Rev 23 5 633 655
-
(2003)
Med Res Rev
, vol.23
, pp. 633-655
-
-
Ho, Y.P.1
Au-Yeung, S.C.2
To, K.K.3
-
6
-
-
0029989716
-
Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line
-
4
-
T Esaki S Nakano N Masumoto H Fujishima Y Niho 1996 Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line Int J Cancer 65 4 479 484
-
(1996)
Int J Cancer
, vol.65
, pp. 479-484
-
-
Esaki, T.1
Nakano, S.2
Masumoto, N.3
Fujishima, H.4
Niho, Y.5
-
7
-
-
0036013613
-
In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: Timing of cisplatin treatment
-
1
-
H Cho T Imada T Oshima M Shiozawa Y Rino Y Takanashi 2002 In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment Gastric Cancer 5 1 43 46
-
(2002)
Gastric Cancer
, vol.5
, pp. 43-46
-
-
Cho, H.1
Imada, T.2
Oshima, T.3
Shiozawa, M.4
Rino, Y.5
Takanashi, Y.6
-
8
-
-
0028134726
-
Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck
-
3
-
S Furukawa M Tsukuda I Mochimatsu T Kokatsu H Satoh M Sakumoto 1994 Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck Auris Nasus Larynx 21 3 181 185
-
(1994)
Auris Nasus Larynx
, vol.21
, pp. 181-185
-
-
Furukawa, S.1
Tsukuda, M.2
Mochimatsu, I.3
Kokatsu, T.4
Satoh, H.5
Sakumoto, M.6
-
9
-
-
0026489375
-
Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line
-
23
-
T Esaki S Nakano T Tatsumoto M Kuroki-Migita K Mitsugi M Nakamura 1992 Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line Cancer Res 52 23 6501 6506
-
(1992)
Cancer Res
, vol.52
, pp. 6501-6506
-
-
Esaki, T.1
Nakano, S.2
Tatsumoto, T.3
Kuroki-Migita, M.4
Mitsugi, K.5
Nakamura, M.6
-
10
-
-
0035149476
-
Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line
-
4A
-
T Tanaka H Masuda M Naito H Tamai 2001 Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line Anticancer Res 21 4A 2463 2469
-
(2001)
Anticancer Res
, vol.21
, pp. 2463-2469
-
-
Tanaka, T.1
Masuda, H.2
Naito, M.3
Tamai, H.4
-
13
-
-
33748292931
-
Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil
-
39
-
HM Robinson R Jones M Walker G Zachos R Brown J Cassidy 2006 Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil Oncogene 25 39 5359 5369
-
(2006)
Oncogene
, vol.25
, pp. 5359-5369
-
-
Robinson, H.M.1
Jones, R.2
Walker, M.3
Zachos, G.4
Brown, R.5
Cassidy, J.6
-
15
-
-
0036570336
-
G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity
-
1
-
JF Mirjolet C Didelot M Barberi-Heyob JL Merlin 2002 G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity Cytometry 48 1 6 13
-
(2002)
Cytometry
, vol.48
, pp. 6-13
-
-
Mirjolet, J.F.1
Didelot, C.2
Barberi-Heyob, M.3
Merlin, J.L.4
|